Skip navigation

Polypharmacy: Effective Management & Stopping Medicines Safely

Monday 21 January 2019
De Vere W1 Conference Centre, London

Follow the conference in Twitter #polypharmacy

“Data from many countries demonstrates that the number of medicines prescribed to individual patients has grown significantly over the last 10-15 years. As the population ages and many people take an increasing number of medicines for multiple long term conditions, polypharmacy has become a key issue in health and social care.  Evidence suggests that multiple morbidity and the associated medications increases a patient’s risk of harm and contributes to hospital admissions and poor therapeutic outcomes. It can be particularly problematic in older people, particularly the frail.” RPS, 2018

“Whilst it is recognised that medicines have had an enormously positive impact on the lives of millions of people, polypharmacy is a significant, complex and growing issue affecting a broad range of people. Naturally, polypharmacy is often linked to the taking of multiple medicines in older people. However, it is important to recognise that it can also affect a wider group of people including children and young people, those from deprived backgrounds, people with mental health problems and those with learning difficulties. It occurs in a wide range of health and social care settings such as hospitals, care homes, prisons and affects many different people including those who are housebound or homeless and those in hospices.

There are many definitions of the term problematic polypharmacy…

· The prescribing of medicines that are no longer clinically indicated or appropriate or optimised for that person

· Where the benefit of a particular medicine does not outweigh the harm

· Where the combination of multiple medicines has the potential to or is actually causing harm to the person

· Where the practicalities of using the medicines prescribed to a person have become unmanageable or are causing harm or distress.” Royal Pharmaceutical Society 2018

This conference focuses on polypharmacy: the effective management and stopping medicines safely in line with the new RPS Guidance.

This conference will enable you to:

• Network with colleagues who are working to improve the management of polypharmacy

• Learn from outstanding practice in stopping medicines safely

• Understand the prescribers role in preventing polypharmacy

• Reflect on national developments and learning including the 2018 RPS Guidance

• Improve the way medication review is managed in your service

• Develop your skills in identifying patients with multiple medicines and preventing overdiagnosis

• Understand how you can improve prescribing in frail older people with comorbidities

• Identify key strategies for deprescribing

• Ensure you are up to date with the latest evidence

• Self assess and reflect on your own practice

• Gain cpd accreditation points contributing to professional development and revalidation evidence

100% of delegates at our previous conference on this subject would recommend it to a colleagues

Book online now
Good Governance Institute
GGI (Good Governance Institute) accredited conferences CPD Member ASGBI (Association of Surgeons of Great Britain and Ireland) professional partner BADS (British Association of Day Surgery) accredited conferences